Profile data is unavailable for this security.
About the company
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
- Revenue in USD (TTM)21.19bn
- Net income in USD1.50bn
- Incorporated2000
- Employees79.61k
- LocationKoninklijke Philips NVAmstelplein 2AMSTERDAM 1096 BCNetherlandsNLD
- Phone+31 205977777
- Fax+31 205977220
- Websitehttps://www.philips.com/
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| Medumo Inc | 14.90% | -- |
| Carestream Health Inc-Healthcare Information Systems Business | 26.07% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Inc. | 2.70bn | 425.10m | 23.64bn | 7.24k | 55.93 | 11.16 | 40.51 | 8.76 | 2.94 | 2.90 | 18.66 | 14.73 | 0.7475 | 3.44 | 5.51 | 372,838.10 | 11.77 | 12.58 | 13.60 | 14.69 | 59.22 | 58.67 | 15.75 | 18.16 | 1.46 | 10.64 | 0.3656 | 48.26 | 11.38 | 10.88 | -9.34 | 3.56 | -0.9581 | 8.16 |
| Zimmer Biomet Holdings Inc | 7.93bn | -81.90m | 31.05bn | 19.00k | -- | 2.57 | 33.65 | 3.92 | -0.4475 | -0.4882 | 38.53 | 58.76 | 0.319 | 0.9495 | 6.57 | 417,236.80 | -0.3385 | 1.26 | -0.3865 | 1.39 | 72.56 | 70.96 | -1.06 | 3.93 | 0.5403 | 4.91 | 0.4085 | 66.57 | 1.66 | 11.40 | -168.51 | -- | 8.43 | 3.71 |
| Koninklijke Philips NV (ADR) | 21.19bn | 1.50bn | 45.31bn | 79.61k | 31.14 | -- | 19.26 | 2.14 | 1.62 | 1.54 | 22.97 | -- | -- | -- | -- | 273,836.50 | -- | 2.44 | -- | 3.56 | 46.34 | 43.80 | 7.13 | 3.81 | -- | 18.74 | -- | 114.41 | 1.92 | -3.80 | 60.07 | 4.79 | -0.3289 | 3.79 |
| Baxter International Inc | 11.08bn | 1.39bn | 46.54bn | 50.00k | 34.89 | 5.95 | 21.35 | 4.20 | 2.61 | 2.97 | 20.84 | 15.31 | 0.6494 | 3.76 | 6.04 | 221,600.00 | 8.14 | 8.53 | 9.62 | 10.86 | 42.65 | 42.28 | 12.54 | 16.27 | 2.10 | 43.42 | 0.3971 | 32.91 | 5.36 | 3.40 | 8.71 | 35.20 | -14.89 | -17.59 |
| Edwards Lifesciences Corp | 4.15bn | 819.70m | 50.68bn | 12.80k | 62.88 | 13.28 | 56.00 | 12.21 | 3.86 | 3.65 | 19.57 | 18.30 | 0.6963 | 1.78 | 8.36 | 324,343.80 | 13.75 | 16.03 | 16.58 | 19.07 | 74.40 | 74.19 | 19.74 | 23.37 | 2.74 | -- | 0.1348 | 0.00 | 8.37 | 12.72 | -15.92 | 13.66 | 17.03 | -- |
| Boston Scientific Corporation | 10.39bn | 1.03bn | 61.40bn | 32.00k | 60.11 | 6.33 | 30.73 | 5.91 | 0.7329 | 0.7741 | 7.38 | 6.96 | 0.441 | 2.26 | 6.16 | 324,750.00 | 4.38 | 2.81 | 5.46 | 3.50 | 70.69 | 70.48 | 9.93 | 6.08 | 0.7713 | 3.40 | 0.5289 | 0.00 | 8.57 | 6.58 | 66.22 | -- | 11.05 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Investment Management LLCas of 30 Sep 2019 | 4.64m | 0.51% |
| Managed Account Advisors LLCas of 30 Sep 2019 | 3.65m | 0.40% |
| Arrowstreet Capital LPas of 30 Sep 2019 | 3.29m | 0.36% |
| Wellington Management Co. LLPas of 30 Sep 2019 | 2.20m | 0.24% |
| Bank of America, NA (Private Banking)as of 30 Sep 2019 | 1.05m | 0.12% |
| Dimensional Fund Advisors LPas of 30 Sep 2019 | 954.86k | 0.11% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2019 | 939.49k | 0.10% |
| Wells Fargo Clearing Services LLCas of 30 Sep 2019 | 890.54k | 0.10% |
| Morgan Stanley Smith Barney LLC (Invt Mgmt)as of 30 Sep 2019 | 879.19k | 0.10% |
| BlackRock Advisors LLCas of 30 Sep 2019 | 872.69k | 0.10% |
